Improve Enrollment through Oncology Referrals
MD Referral | Traditional recruitment methods typically underperform, especially in oncology studies with highly targeted eligibility criteria. ClinOne enhances your efforts by communicating directly with more than 570,000 global physicians and oncologists in our proprietary network who are located nearby your clinical sites and have patients to refer. With the support of MD Referral to automate “Dear Doctor” letters, one oncology study sponsor achieved their enrollment goal of 400 patients 5 months early across existing sites. ClinOne helps you expand your patient pool, increases the visibility of your trial with local referring specialists, and supports increased enrollment with a lower screen fail rate.
Simplify Complex Patient Consents
eConsent | Oncology studies often have complex consent workflows including multiple forms of consent and numerous protocol amendments through the trial. Whether remote or on-site, eConsent on the ClinOne platform eliminates risk by fostering communication between sites and patients, and by automatically ensuring proper document management and real-time tracking of consents and re-consents. eConsent ensures patients and families understand the benefits and risks of the study so they can make an informed participation decision, which in turn supports increased compliance and retention, while minimizing or eliminating consent-related audit findings.
Make It Easy for Patients (and Families) to Participate
Engage & Interact | No patient participates in an oncology trial alone. ClinOne’s platform provides a single BYOD solution for patients to review study information, share updates with family members and HCPs, and manage their trial activities including secure site communication, virtual and on-site visit scheduling using their own calendar, transportation with Uber Health, and telemedicine visits. ClinOne helps guide patients and families through a stressful and challenging time to monitor safety and progress in real time, improve compliance and reduce missed visit rate by 50%, and connect a personal care community – without getting in the way of their daily lives.
Increase Safety and Capture Real-world Evidence with Wearables
Connected Devices | While most outcomes in oncology studies focus on tumor response and survivability, quality of life is a critical measure of success for overall patient well-being. Integrating objective and biometric data from convenient wearable sensors can improve safety monitoring (e.g. SPO2, fall detection, blood pressure) and provide real-world insight into activity, sleep, and other digital endpoints. Increasingly, regulatory authorities are reviewing these data to make labelling decisions and assess the true impact of your investigational treatment on patients. Ensure you have the complete picture of patient response with connected devices on the ClinOne platform.
Improve Dosing for Self-administered Medication
Dosing Manager | A specific subset of oncology studies requires patients to self-administer medication. ClinOne’s dosing compliance module raises dosing compliance to industry leading compliance rates of 92% dosing compliance at 12-months on study. Patients can complete their dosing diary from personal devices, further increasing convenience and compliance.